Prognostic implication of inflammation-based scores in patients with metastatic pancreatic cancer (mPC) treated with first-line nab-paclitaxel plus gemcitabine (AG)

被引：0
|
作者：
Ip, H. N. N. [1 ]
Hwang, I. [2 ]
Kang, J. [2 ]
Kim, K-P. [2 ]
Jeong, J. H. [2 ]
Chang, H-M. [2 ]
Ryoo, B-Y. [2 ]
Yoo, C. [2 ]
机构：
[1] Chinese Univ Hong Kong, Med, Hong Kong, Peoples R China
[2] Asan Med Ctr, Oncol, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
193P
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [41] First-Line Gemcitabine, Nab-Paclitaxel, and Oxaliplatin Chemotherapy With Itraconazole in Patients With Metastatic Pancreatic Cancer: A Single Institution Experience
    Sawasaki, Miyuki
    Tsubamoto, Hiroshi
    Sugihara, Ayako
    Ikuta, Shinichi
    Sakai, Yoshiyuki
    Osaki, Yukio
    Sonoda, Takashi
    ANTICANCER RESEARCH, 2022, 42 (12) : 6063 - 6069
  • [42] Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer
    Han, Sung Yong
    Kim, Dong Uk
    Seol, Young Mi
    Kim, Suk
    Lee, Nam Kyung
    Hong, Seung Baek
    Seo, Hyung-Il
    WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (17) : 3718 - 3729
  • [43] Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer
    Sung Yong Han
    Dong Uk Kim
    Young Mi Seol
    Suk Kim
    Nam Kyung Lee
    Seung Baek Hong
    Hyung-Il Seo
    World Journal of Clinical Cases, 2020, (17) : 3718 - 3729
  • [44] nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: Real life
    Cidon, E. Una
    Alonso, P.
    ANNALS OF ONCOLOGY, 2020, 31 : S109 - S109
  • [45] Efficacy and safety of Nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer
    Filipazzi, V.
    Dalu, D.
    Isabella, L.
    Tosca, N.
    Ferrario, S.
    Gambaro, A.
    Somma, L.
    Fasola, C.
    Pellegrini, I.
    Bombonati, G.
    Curcio, R.
    Damiani, E.
    Cattaneo, M. T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [46] Nab-paclitaxel and gemcitabine for the treatment of patients with metastatic pancreatic cancer
    Borazanci, Erkut
    Von Hoff, Daniel D.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 8 (07) : 739 - 747
  • [47] Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
    E Gabriela Chiorean
    Daniel D Von Hoff
    Josep Tabernero
    Robert El-Maraghi
    Wen Wee Ma
    Michele Reni
    Marion Harris
    Robert Whorf
    Helen Liu
    Jack Shiansong Li
    Victoria Manax
    Alfredo Romano
    Brian Lu
    David Goldstein
    British Journal of Cancer, 2016, 115 : 188 - 194
  • [48] Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
    Chiorean, E. Gabriela
    Von Hoff, Daniel D.
    Tabernero, Josep
    El-Maraghi, Robert
    Ma, Wen Wee
    Reni, Michele
    Harris, Marion
    Whorf, Robert
    Liu, Helen
    Li, Jack Shiansong
    Manax, Victoria
    Romano, Alfredo
    Lu, Brian
    Goldstein, David
    BRITISH JOURNAL OF CANCER, 2016, 115 (02) : 188 - 194
  • [49] First line nab-paclitaxel plus gemcitabine in elderly metastatic pancreatic patients: a good choice beyond age
    Petrillo, Angelica
    Pappalardo, Annalisa
    Calabrese, Filomena
    Tirino, Giuseppe
    Pompella, Luca
    Ventriglia, Jole
    Laterza, Maria Maddalena
    Caterino, Marianna
    Sforza, Vincenzo
    Iranzo, Vega
    Biglietto, Maria
    Orditura, Michele
    Ciardiello, Fortunato
    Conzo, Giovanni
    Molino, Carlo
    De Vita, Ferdinando
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 10 (05) : 910 - 917
  • [50] Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma
    Trestini, Ilaria
    Carbognin, Luisa
    Peretti, Umberto
    Sperduti, Isabella
    Caldart, Alberto
    Tregnago, Daniela
    Avancini, Alice
    Auriemma, Alessandra
    Orsi, Giulia
    Pilotto, Sara
    Frulloni, Luca
    Capurso, Gabriele
    Bria, Emilio
    Reni, Michele
    Tortora, Giampaolo
    Milella, Michele
    FRONTIERS IN ONCOLOGY, 2021, 11
12345